Surgical management of low-stage nonseminomatous germ cell testicular cancer

BJU International

Volumn 104, Issue 9 B, 2009, Pages 1362-1368

  Stephenson, Andrew J ^a   Klein, Eric A ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

Chemotherapy; Embryonal; Germ cell; Lymph node excision; Retroperitoneum; Testicular neoplasms

Indexed keywords

ALPHA FETOPROTEIN; ANTINEOPLASTIC AGENT; BLEOMYCIN; CHORIONIC GONADOTROPIN; CISPLATIN; ETOPOSIDE; LACTATE DEHYDROGENASE;

ADJUVANT CHEMOTHERAPY; ADJUVANT THERAPY; CANCER CHEMOTHERAPY; CANCER EPIDEMIOLOGY; CANCER RECURRENCE; CANCER RELAPSE; CANCER STAGING; CARDIOVASCULAR DISEASE; CHYLOUS ASCITES; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; EJACULATION DISORDER; EMBRYONAL CARCINOMA; HUMAN; LAPAROSCOPIC SURGERY; LYMPH NODE DISSECTION; LYMPHADENOPATHY; LYMPHOCELE; METASTASIS; MORBIDITY; MULTIPLE CYCLE TREATMENT; NON SEMINOMATOUS GERMINOMA; ORCHIECTOMY; OTOTOXICITY; PERIPHERAL NEUROPATHY; PRIMARY TUMOR; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RAYNAUD PHENOMENON; RETROPERITONEAL CANCER; REVIEW; RISK ASSESSMENT; RISK FACTOR; SECOND CANCER; SMALL INTESTINE OBSTRUCTION; SURGICAL TECHNIQUE; SURVIVAL RATE; SYSTEMIC DISEASE; TERATOMA;

CHEMOTHERAPY, ADJUVANT; HUMANS; LAPAROSCOPY; LYMPH NODE EXCISION; LYMPHATIC METASTASIS; MALE; NEOPLASM RECURRENCE, LOCAL; NEOPLASMS, GERM CELL AND EMBRYONAL; ORCHIECTOMY; RETROPERITONEAL NEOPLASMS; RISK ASSESSMENT; RISK FACTORS; TESTICULAR NEOPLASMS;

EID: 70350442740     PISSN: 14644096     EISSN: 1464410X     Source Type: Journal    
DOI: 10.1111/j.1464-410X.2009.08860.x     Document Type: Review

References (66)

1. Donohue JP, Thornhill JA, Foster RS, Rowland RG, Bihrle R. Retroperitoneal lymphadenectomy for clinical stage A testis cancer (1965-89): modifications of technique and impact on ejaculation. J Urol 1993 149 : 237 243
2. Hermans BP, Sweeney CJ, Foster RS, Einhorn LE, Donohue JP. Risk of systemic metastases in clinical stage I nonseminoma germ cell testis tumor managed by retroperitoneal lymph node dissection. J Urol 2000 163 : 1721 1724
3. Nicolai N, Miceli R, Artusi R, Piva L, Pizzocaro G, Salvioni R. A simple model for predicting nodal metastasis in patients with clinical stage I nonseminomatous germ cell testicular tumors undergoing retroperitoneal lymph node dissection only. J Urol 2004 171 : 172 176
4. Stephenson AJ, Bosl GJ, Motzer RJ et al. Retroperitoneal lymph node dissection for nonseminomatous germ cell testicular cancer: impact of patient selection factors on outcome. J Clin Oncol 2005 23 : 2781 2788
5. Amato RJ, Ro JY, Ayala AG, Swanson DA. Risk-adapted treatment for patients with clinical stage I nonseminomatous germ cell tumor of the testis. Urology 2004 63 : 144 148
6. Bohlen D, Borner M, Sonntag RW, Fey MF, Studer UE. Long-term results following adjuvant chemotherapy in patients with clinical stage I testicular nonseminomatous malignant germ cell tumors with high risk factors. J Urol 1999 161 : 1148 1152
7. Cullen MH, Stenning SP, Parkinson MC et al. Short-course adjuvant chemotherapy in high-risk stage I nonseminomatous germ cell tumors of the testis: a Medical Research Council report. J Clin Oncol 1996 14 : 1106 1113
8. Oliver RT, Ong J, Shamash J et al. Long-term follow-up of Anglian Germ Cell Cancer Group surveillance versus patients with Stage 1 nonseminoma treated with adjuvant chemotherapy. Urology 2004 63 : 556 561
9. Daugaard G, Petersen PM, Rorth M. Surveillance in stage I testicular cancer. APMIS 2003 111 : 76 83
10. Read G, Stenning SP, Cullen MH et al. Medical Research Council prospective study of surveillance for stage I testicular teratoma. Medical Research Council Testicular Tumors Working Party. J Clin Oncol 1992 10 : 1762 1768
11. Sharir S, Jewett MA, Sturgeon JF et al. Progression detection of stage I nonseminomatous testis cancer on surveillance: implications for the followup protocol. J Urol 1999 161 : 472 475
12. Donohue JP, Thornhill JA, Foster RS, Rowland RG, Bihrle R. Clinical stage B non-seminomatous germ cell testis cancer: the Indiana University experience (1965-89) using routine primary retroperitoneal lymph node dissection. Eur J Cancer 1995 31A : 1599 1604
13. Stephenson AJ, Bosl GJ, Motzer RJ, Bajorin DF, Stasi JP, Sheinfeld J. Nonrandomized comparison of primary chemotherapy and retroperitoneal lymph node dissection for clinical stage IIA and IIB nonseminomatous germ cell testicular cancer. J Clin Oncol 2007 25 : 5597 5602
14. Weissbach L, Bussar-Maatz R, Flechtner H, Pichlmeier U, Hartmann M, Keller L. RPLND or primary chemotherapy in clinical stage IIA/B nonseminomatous germ cell tumors? Results of a prospective multicenter trial including quality of life assessment. Eur Urol 2000 37 : 582 594
15. Logothetis CJ, Swanson DA, Dexeus F et al. Primary chemotherapy for clinical stage II nonseminomatous germ cell tumors of the testis: a follow-up of 50 patients. J Clin Oncol 1987 5 : 906 911
16. Culine S, Theodore C, Court BH, Perrin JL, Droz JP. Evaluation of primary standard cisplatin-based chemotherapy for clinical stage II non-seminomatous germ cell tumours of the testis. Br J Urol 1997 79 : 258 262
17. Horwich A, Norman A, Fisher C, Hendry WF, Nicholls J, Dearnaley DP. Primary chemotherapy for stage II nonseminomatous germ cell tumors of the testis. J Urol 1994 151 : 72 7
18. Ondrus D, Hornak M, Matoska J, Kausitz J, Belan V. Primary chemotherapy in the management of low stage (IIA and IIB) non-seminomatous germ cell testicular tumours. Int Urol Nephrol 1992 24 : 299 304
19. Peckham MJ, Hendry WF. Clinical stage II non-seminomatous germ cell testicular tumours. Results of management by primary chemotherapy. Br J Urol 1985 57 : 763 768
20. Donohue JP, Zachary JM, Maynard BR. Distribution of nodal metastases in nonseminomatous testis cancer. J Urol 1982 128 : 315 320
21. Sheinfeld J. Nonseminomatous germ cell tumors of the testis: current concepts and controversies. Urology 1994 44 : 2 14
22. Foster RS, Baniel J, Leibovitch I et al. Teratoma in the orchiectomy specimen and volume of metastasis are predictors of retroperitoneal teratoma in low stage nonseminomatous testis cancer. J Urol 1996 155 : 1943 1945
23. Albers P, Siener R, Kliesch S et al. Risk factors for relapse in clinical stage I nonseminomatous testicular germ cell tumors: results of the German Testicular Cancer Study Group Trial. J Clin Oncol 2003 21 : 1505 1512
24. Albers P, Siener R, Krege S et al. Randomized phase III trial comparing retroperitoneal lymph node dissection with one course of bleomycin and etoposide plus cisplatin chemotherapy in the adjuvant treatment of clinical stage I Nonseminomatous testicular germ cell tumors: AUO trial AH 01/94 by the German Testicular Cancer Study Group. J Clin Oncol 2008 26 : 2966 2972
25. Bredael JJ, Vugrin D, Whitmore WF Jr. Autopsy findings in 154 patients with germ cell tumors of the testis. Cancer 1982 50 : 548 551
26. Sheinfeld J, Motzer RJ, Rabbani F, McKiernan J, Bajorin D, Bosl GJ. Incidence and clinical outcome of patients with teratoma in the retroperitoneum following primary retroperitoneal lymph node dissection for clinical stages I and IIA nonseminomatous germ cell tumors. J Urol 2003 170 : 1159 1162
27. Logothetis CJ, Samuels ML, Trindade A, Johnson DE. The growing teratoma syndrome. Cancer 1982 50 : 1629 1635
28. Motzer RJ, Amsterdam A, Prieto V et al. Teratoma with malignant transformation: diverse malignant histologies arising in men with germ cell tumors. J Urol 1998 159 : 133 138
29. Sheinfeld J. Risks of the uncontrolled retroperitoneum. Ann Surg Oncol 2003 10 : 100 101
30. Baniel J, Foster RS, Gonin R, Messemer JE, Donohue JP, Einhorn LH. Late relapse of testicular cancer. J Clin Oncol 1995 13 : 1170 1176
31. George DW, Foster RS, Hromas RA et al. Update on late relapse of germ cell tumor: a clinical and molecular analysis. J Clin Oncol 2003 21 : 113 122
32. Sharp DS, Carver BS, Eggener SE et al. Clinical outcome and predictors of survival in late relapse of germ cell tumor. J Clin Oncol 2008 26 : 5524 5529
33. Baniel J, Foster RS, Rowland RG, Bihrle R, Donohue JP. Complications of primary retroperitoneal lymph node dissection. J Urol 1994 152 : 424 427
34. McLeod DG, Weiss RB, Stablein DM et al. Staging relationships and outcome in early stage testicular cancer: a report from the Testicular Cancer Intergroup Study. J Urol 1991 145 : 1178 1183
35. Subramanian VS, Nguyen CT, Stephenson AJ, Klein EA. Complications of open primary and post-chemotherapy retroperitoneal lymph node dissection for testicular cancer. Urol Oncol 2009 (in press)
36. Bokemeyer C, Berger CC, Kuczyk MA, Schmoll HJ. Evaluation of long-term toxicity after chemotherapy for testicular cancer. J Clin Oncol 1996 14 : 2923 2932 (Pubitemid 26371450)
37. Meinardi MT, Gietema JA, van der Graaf WT et al. Cardiovascular morbidity in long-term survivors of metastatic testicular cancer. J Clin Oncol 2000 18 : 1725 1732
38. Travis LB, Fossa SD, Schonfeld SJ et al. Second cancers among 40,576 testicular cancer patients: focus on long-term survivors. J Natl Cancer Inst 2005 97 : 1354 1365
39. van den Belt-Dusebout AW, de Wit R, Gietema JA et al. Treatment-specific risks of second malignancies and cardiovascular disease in 5-year survivors of testicular cancer. J Clin Oncol 2007 25 : 4370 4378
40. Donohue JP, Foster RS. Retroperitoneal lymphadenectomy in staging and treatment. The development of nerve-sparing techniques. Urol Clin North Am 1998 25 : 461 468
41. Richie JP. Clinical stage 1 testicular cancer: the role of modified retroperitoneal lymphadenectomy. J Urol 1990 144 : 1160 1163
42. Jewett MA, Kong YS, Goldberg SD et al. Retroperitoneal lymphadenectomy for testis tumor with nerve sparing for ejaculation. J Urol 1988 139 : 1220 1224
43. Stephenson AJ, Bosl GJ, Bajorin DF, Stasi J, Motzer RJ, Sheinfeld J. Retroperitoneal lymph node dissection in patients with low stage testicular cancer with embryonal carcinoma predominance and/or lymphovascular invasion. J Urol 2005 174 : 557 560
44. Fernandez EB, Moul JW, Foley JP, Colon E, McLeod DG. Retroperitoneal imaging with third and fourth generation computed axial tomography in clinical stage I nonseminomatous germ cell tumors. Urology 1994 44 : 548 552
45. Leibovitch L, Foster RS, Kopecky KK, Donohue JP. Improved accuracy of computerized tomography based clinical staging in low stage nonseminomatous germ cell cancer using size criteria of retroperitoneal lymph nodes. J Urol 1995 154 : 1759 1763
46. Hilton S, Herr HW, Teitcher JB, Begg CB, Castellino RA. CT detection of retroperitoneal lymph node metastases in patients with clinical stage I testicular nonseminomatous germ cell cancer: assessment of size and distribution criteria. AJR Am J Roentgenol 1997 169 : 521 525
47. Oechsle K, Hartmann M, Brenner W et al. [18F]Fluorodeoxyglucose positron emission tomography in nonseminomatous germ cell tumors after chemotherapy: the German multicenter positron emission tomography study group. J Clin Oncol 2008 26 : 5930 5935
48. Alexandre J, Fizazi K, Mahe C et al. Stage I non-seminomatous germ-cell tumours of the testis: identification of a subgroup of patients with a very low risk of relapse. Eur J Cancer 2001 37 : 576 582
49. Heidenreich A, Sesterhenn IA, Mostofi FK, Moul JW. Prognostic risk factors that identify patients with clinical stage I nonseminomatous germ cell tumors at low risk and high risk for metastasis. Cancer 1998 83 : 1002 1011
50. Roeleveld TA, Horenblas S, Meinhardt W, van de Vijver M, Kooi M, ten Bokkel Huinink WW. Surveillance can be the standard of care for stage I nonseminomatous testicular tumors and even high risk patients. J Urol 2001 166 : 2166 2170
51. Sogani PC, Perrotti M, Herr HW, Fair WR, Thaler HT, Bosl G. Clinical stage I testis cancer: long-term outcome of patients on surveillance. J Urol 1998 159 : 855 858
52. Sweeney CJ, Hermans BP, Heilman DK, Foster RS, Donohue JP, Einhorn LH. Results and outcome of retroperitoneal lymph node dissection for clinical stage I embryonal carcinoma - predominant testis cancer. J Clin Oncol 2000 18 : 358 362
53. Vergouwe Y, Steyerberg EW, Eijkemans MJ, Albers P, Habbema JD. Predictors of occult metastasis in clinical stage I nonseminoma: a systematic review. J Clin Oncol 2003 21 : 4092 4099
54. Bosl GJ, Motzer RJ. Testicular germ-cell cancer. N Engl J Med 1997 337 : 242 253
55. Davis BE, Herr HW, Fair WR, Bosl GJ. The management of patients with nonseminomatous germ cell tumors of the testis with serologic disease only after orchiectomy. J Urol 1994 152 : 111 113
56. Rabbani F, Sheinfeld J, Farivar-Mohseni H et al. Low-Volume nodal metastases detected at retroperitoneal lymphadenectomy for testicular cancer: pattern and prognostic factors for relapse. J Clin Oncol 2001 19 : 2020 2025
57. Williams SD, Stablein DM, Einhorn LH et al. Immediate adjuvant chemotherapy versus observation with treatment at relapse in pathological stage II testicular cancer. N Engl J Med 1987 317 : 1433 1438
58. Socinski MA, Garnick MB, Stomper PC, Fung CY, Richie JP. Stage II nonseminomatous germ cell tumors of the testis: an analysis of treatment options in patients with low Volume retroperitoneal disease. J Urol 1988 140 : 1437 1441
59. Behnia M, Foster R, Einhorn LH, Donohue J, Nichols CR. Adjuvant bleomycin, etoposide and cisplatin in pathological stage II non-seminomatous testicular cancer: the Indiana University experience. Eur J Cancer 2000 36 : 472 475
60. Kondagunta GV, Sheinfeld J, Mazumdar M et al. Relapse-free and overall survival in patients with pathologic stage II nonseminomatous germ cell cancer treated with etoposide and cisplatin adjuvant chemotherapy. J Clin Oncol 2004 22 : 464 467
61. Eggener SE, Carver BS, Sharp DS, Motzer RJ, Bosl GJ, Sheinfeld J. Incidence of disease outside modified retroperitoneal lymph node dissection templates in clinical stage I or IIA nonseminomatous germ cell testicular cancer. J Urol 2007 177 : 937 943 (Pubitemid 46216360)
62. Bhayani SB, Ong A, Oh WK, Kantoff PW, Kavoussi LR. Laparoscopic retroperitoneal lymph node dissection for clinical stage I nonseminomatous germ cell testicular cancer: a long-term update. Urology 2003 62 : 324 327
63. Janetschek G, Hobisch A, Peschel R, Hittmair A, Bartsch G. Laparoscopic retroperitoneal lymph node dissection for clinical stage I nonseminomatous testicular carcinoma: long-term outcome. J Urol 2000 163 : 1793 1796
64. Nelson JB, Chen RN, Bishoff JT et al. Laparoscopic retroperitoneal lymph node dissection for clinical stage I nonseminomatous germ cell testicular tumors. Urology 1999 54 : 1064 1067
65. Janetschek G. Laparoscopic retroperitoneal lymph node dissection. Urol Clin North Am 2001 28 : 107 114 (Pubitemid 32224489)
66. Nielsen ME, Lima G, Schaeffer EM et al. Oncologic efficacy of laparoscopic RPLND in treatment of clinical stage I nonseminomatous germ cell testicular cancer. Urology 2007 70 : 1168 1172